Answers are grounded in this paper and cite their sources.
MS-SUPPORT was strongly endorsed by patients and is feasible to use in clinical settings. MS-SUPPORT increased the short-term probability of taking and adhering to a DMT, and improved long-term mental health. Study limitations include selection bias, response bias, social desirability bias, and recall bias. Exploring approaches to reinforcement and monitoring its implementation in real-world settings should provide further insights into the value and utility of this new SDM tool.
No takes yet. Share an insight, caveat, or question.
Col et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: